An Oncogenic Role for ETV1 in Melanoma
Open accessPublished version of a preprint
The DOI matches its Crossref record; 29 of the 31 references it cites were found in a registry or an index.
Abstract
Copy gains involving chromosome 7p represent one of the most common genomic alterations found in melanomas, suggesting the presence of “driver” cancer genes. We identified several tumor samples that harbored focal amplifications situated at the peak of common chromosome 7p gains, in which the minimal common overlapping region spanned the ETV1 oncogene. Fluorescence in situ hybridization analysis revealed copy gains spanning the ETV1 locus in >40% of cases, with ETV1 amplification (>6 copies/cell) present in 13% of primary and 18% of metastatic melanomas. Melanoma cell lines, including those with ETV1 amplification, exhibited dependency on ETV1 expression for proliferation and anchorage-independent growth. Moreover, overexpression of ETV1 in combination with oncogenic NRASG12D transformed primary melanocytes and promoted tumor formation in mice. ETV1 overexpression elevated microphthalmia-associated transcription factor expression in immortalized melanocytes, which was necessary for ETV1-dependent oncogenicity. These observations implicate deregulated ETV1 in melanoma genesis and suggest a pivotal lineage dependency mediated by oncogenic ETS transcription factors in this malignancy. Cancer Res; 70(5); 2075–84
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition to the chromosome rearrangements described above, there is mounting evidence for an oncogenic role for dysregulation of ETS genes in prostate (188, 188a), melanoma (189), and gastrointestinal stromal tumors (140).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674 · cited 2×
“Chromosome 7q contains the BRAF oncogene, which commonly undergoes activating point mutations in melanoma (4).”
BackgroundRecurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
Self-citationDistinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747 · cited 2×
“These results were consistent with SNP array and comparative genomic hybridization results reported here and elsewhere (2, 3).”
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548 · cited 5×
“These results are reminiscent of studies on MITF dependency in melanoma: Focal amplifications targeting MITF are found in only 10% to 15% of melanomas (10), yet MITF dependency is broadly operant and not exclusive to MITF-amplified tumors.”
BackgroundResultSelf-citationHigh-throughput oncogene mutation profiling in human cancer
Thomas, R. K., Baker, A. C., DeBiasi, R. M., Winckler, W., LaFramboise, T., Lin, W. M., Wang, M., Feng, W., Zander, T., MacConaill, L. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1975 · Cited by 988 · cited 1×
“However, most melanomas also harbor activating NRAS or BRAF mutations that result in aberrant MAP kinase pathway activation (4, 12, 13).”
BackgroundSelf-citationDistinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Tomlins, S. A., Laxman, B., Dhanasekaran, S. M., Helgeson, B. E., Cao, X., Morris, D. S., Menon, A., Jing, X., Cao, Q., Han, B., et al. (2007) · Nature · doi:10.1038/nature06024 · Cited by 844 · cited 2×
“Most commonly, these translocations interpose the promoter and 5′ coding exons of the TMPRSS2 gene upstream of an ETS factor gene (ERG, ETV1, ETV4, or ETV5), resulting in androgen-dependent regulation and elevated expression of these genes (7, 19); results described herein add malignant melanoma to the growing list of…”
BackgroundSelf-citationMolecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Carver, B. S., Tran, J., Gopalan, A., Chen, Z., Shaikh, S., Carracedo, A., Alimonti, A., Nardella, C., Varmeh, S., Scardino, P. T., et al. (2009) · Nature Genetics · doi:10.1038/ng.370 · Cited by 659
MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes
Hemesath, T. J., Price, E. R., Takemoto, C., Badalian, T., & Fisher, D. E. (1998) · Nature · doi:10.1038/34681 · Cited by 630 · cited 1×
“Our observations imply that MITF, which itself is activated by MAP kinase (28), may participate in amelanocytic transcriptional program that includes ETV1 and possibly other factors.”
BackgroundSelf-citationPratilas, C. A., Taylor, B. S., Ye, Q., Viale, A., Sander, C., Solit, D. B., & Rosen, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900780106 · Cited by 614
Cited by
Targeting transcription factors in cancer — from undruggable to reality
Bushweller, J. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0196-7 · Cited by 919
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756
“We previously demonstrated an oncogenic role for ETV1 in melanoma, whose dysregulated expression was associated with upregulation of microphthalmia-associated transcription factor (MITF) 21 , the master melanocyte transcriptional regulator and a melanoma lineage survival oncogene 22 .”
Self-citationPersonalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
Roychowdhury, S., Iyer, M. K., Robinson, D. R., Lonigro, R. J., Wu, Y.-M., Cao, X., Kalyana-Sundaram, S., Sam, L., Balbin, O. A., Quist, M. J., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003161 · Cited by 628
“ScienceTr recent study demonstrated amplification of another ETS transcription factor oncogene (ETV1) in melanoma (31).”
BackgroundMelanoma: from mutations to medicine
Tsao, H., Chin, L., Garraway, L. A., & Fisher, D. E. (2012) · Genes & Development · doi:10.1101/gad.191999.112 · Cited by 496
Self-citationGenomic and biochemical insights into the specificity of ETS transcription factors
Hollenhorst, P. C., McIntosh, L. P., & Graves, B. J. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.79.081507.103945 · Cited by 490
“In addition to the chromosome rearrangements described above, there is mounting evidence for an oncogenic role for dysregulation of ETS genes in prostate (188, 188a), melanoma (189), and gastrointestinal stromal tumors (140).”
Metadata
- Authors
- Jané-Valbuena, J., Widlund, H. R., Perner, S., Johnson, L. A., Dibner, A. C., Lin, W. M., Baker, A. C., Nazarian, R. M., Vijayendran, K. G., Sellers, W. R., Hahn, W. C., Duncan, L. M., Rubin, M. A., Fisher, D. E., & Garraway, L. A.
- Affiliations
- Authors' Affiliations: Departments of 1Medical Oncology and 2Pediatric Oncology and 3Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School; 4Department of Pathology, Harvard Medical School; 5Department of Pathology, Brigham and Women's Hospital; 6Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts; 7Broad Institute of M.I.T. and Harvard and 8Novartis Institutes for Biomedical Research, Cambridge, Massachusetts
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Garraway, Levi A.
- ORCID
- Venue
- Cancer Research
- Published
- 2010-02-28
- Volume
- 70
- Issue
- 5
- Pages
- 2075-2084
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- PMC
- PMC2846410
- OpenAlex
- W2159175397
- Cited by
- 115
- References
- 31
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 7 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 8 · 2016: 3 · 2015: 8 · 2014: 12 · 2013: 10 · 2012: 15
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust
- National Institutes of Health (DP2OD002750)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR043369)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- ETV1, melanoma, gene amplification, driver genes, ETS transcription factors, NRAS G12D, microphthalmia-associated transcription factor, melanocyte transformation, anchorage-independent growth, metastatic melanoma
- MeSH terms
- Animals, Cell Transformation, Neoplastic, DNA-Binding Proteins, Female, Gene Amplification, Humans, Melanoma, Mice, Nude, Oncogenes, Genes, ras, Transcription Factors, Transplantation, Heterologous, Up-Regulation, Oligonucleotide Array Sequence Analysis, Polymorphism, Single Nucleotide, Proto-Oncogene Proteins B-raf, Mice, Microphthalmia-Associated Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Oncogenic Role for ETV1 in Melanoma. https://app.cochat.ai/papers/10.1158/0008-5472.can-09-3092
- The paper
- Jané-Valbuena, J., Widlund, H. R., Perner, S., Johnson, L. A., Dibner, A. C., Lin, W. M., Baker, A. C., Nazarian, R. M., Vijayendran, K. G., Sellers, W. R., Hahn, W. C., Duncan, L. M., Rubin, M. A., Fisher, D. E., & Garraway, L. A. (2010). An Oncogenic Role for ETV1 in Melanoma. Cancer Research. https://doi.org/10.1158/0008-5472.can-09-3092
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.